2017 Oncology Nursing Drug Handbook / Edition 21

2017 Oncology Nursing Drug Handbook / Edition 21

ISBN-10:
1284117189
ISBN-13:
9781284117189
Pub. Date:
12/02/2016
Publisher:
Jones & Bartlett Learning
ISBN-10:
1284117189
ISBN-13:
9781284117189
Pub. Date:
12/02/2016
Publisher:
Jones & Bartlett Learning
2017 Oncology Nursing Drug Handbook / Edition 21

2017 Oncology Nursing Drug Handbook / Edition 21

$99.95
Current price is , Original price is $99.95. You
$99.95 
  • SHIP THIS ITEM
    Qualifies for Free Shipping
  • PICK UP IN STORE
    Check Availability at Nearby Stores
  • SHIP THIS ITEM

    Temporarily Out of Stock Online

    Please check back later for updated availability.


Overview

Written especially for nurses caring for patients with cancer, the 2017 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration.

Completely revised and updated, the 2017 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs.

New drugs include: alectinib (Alecensa), atezolizumab (Tecentriq), cabozantinib tablets (Cabometyx), cabozantinib capsules (Cometriq), cobimetinib tablets (Cotellic), colistin/polymixin B, clotrimazole, daratumumab (Darzalex), elotuzumab (Empliciti), irinotecan liposome injection (Onivyde), ixazomib (Ninlaro), melphalan for injection (Evoela), necitumumab (Portrazza), osimertinib (Targrisso), pentamidine, posaconazole, peramivir, rolapitant (Varubi) , talimogene laherparepvec (Imlygic), Tamiflu, trabectedin (Yondelis), uridine triacetate (Vistogard granules), venetoclax (Venclexta), vincristine liposome injection (Marqibo), and zanamivir.

Product Details

ISBN-13: 9781284117189
Publisher: Jones & Bartlett Learning
Publication date: 12/02/2016
Pages: 1636
Product dimensions: 5.50(w) x 8.50(h) x 2.50(d)

About the Author

Oncology Nursing Consultant, Kilauea, Hawaii


Mary Ann Lee Professor of Oncology Nursing, University of Missouri, St. Louis, Research Scientist, Siteman Cancer Center

Table of Contents

Section I Cancer Treatment
Chapter 1 Introduction to Chemotherapy Drugs
Chapter 2 Biologic Response Modifier Therapy
Chapter 3 Cytoprotective Agents
Chapter 4 Molecularly Targeted Therapies
Chapter 5 Chemobiotherapy for Noncancer Diseases
Section II Symptom Management
Chapter 6 Pain
Chapter 7 Nausea and Vomiting
Chapter 8 Anorexia and Cachexia
Chapter 9 Anxiety and Depression
Section III Complications
Chapter 10 Managing Tumor-Related Skeletal Events and Hypercalcemia
Chapter 11 Infection
Chapter 12 Constipation
Chapter 13 Diarrhea
Appendix Occupational Exposure to Hazardous Drugs
Appendix Common Terminology Criteria for Adverse
From the B&N Reads Blog

Customer Reviews